Fred Hutchinson Cancer Center
Clinical trials sponsored by Fred Hutchinson Cancer Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a website and a coach help cancer survivors plan End-of-Life care? Results expected Sep 2026 (estimated)
- Poop pills may shield stem cell patients from deadly immune attack Results expected Sep 2026 (estimated)
- Free money for cancer patients: $1,000 monthly cash cards tested in new study Results expected Dec 2026 (estimated)
- New combo aims to make resistant prostate cancer vulnerable to radiation Results expected Dec 2026 (estimated)
- Can restorative justice help close the lung cancer screening gap? Results expected Dec 2026 (estimated)
-
Can a digital kitchen program help breast cancer survivors eat healthier?
Disease control Stopped earlyThis pilot study tests a remotely-delivered nutrition and cooking program called MIND for stage I-III breast cancer survivors. The program is delivered online through the Cook for Your Life platform and aims to improve diet quality. The study will enroll 49 participants to see if…
Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Which Pre-Transplant chemo works best for MDS/AML? new trial aims to find out
Disease control Stopped earlyThis phase II trial tests two different chemotherapy combinations (treosulfan-based vs. clofarabine-based) given before a donor stem cell transplant in adults with myelodysplastic syndromes or acute myeloid leukemia. The goal is to see which regimen leads to better relapse-free s…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Engineered T-Cells take aim at Hard-to-Treat pancreatic cancer
Disease control Stopped earlyThis early-phase trial tests a personalized cell therapy for people with metastatic pancreatic cancer. A patient's own T-cells are genetically modified to recognize and attack mesothelin, a protein found on many pancreatic cancer cells. Before receiving the modified cells, patien…
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Blood cancer transplant study tests safer GVHD prevention
Disease control Stopped earlyThis phase 2 trial tested two different drug combinations to prevent graft-versus-host disease (GVHD) in 150 people with blood cancers receiving a stem cell transplant from an unrelated donor. Both combinations used cyclosporine and sirolimus, plus either mycophenolate mofetil or…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can extra care after transplant help older patients live better?
Disease control Stopped earlyThis study tested two extra care programs—supportive palliative care and clinical management of other health issues—for older or frail patients who had a donor stem cell transplant. The goal was to see if these programs could improve quality of life and survival compared to stand…
Phase 2/3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can an antiviral drug help sepsis patients breathe on their own sooner?
Disease control Stopped earlyThis phase 3 trial tested whether the antiviral drug ganciclovir could prevent reactivation of cytomegalovirus (CMV) in adults with sepsis who needed a breathing machine. The study enrolled 205 CMV-positive patients in the ICU with acute respiratory failure. Participants received…
Phase 3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Exercise may alter gut bacteria in colon cancer survivors, small study hopes to find out
Knowledge-focused Stopped earlyThis study tests whether a moderate-to-vigorous exercise program can change the gut bacteria of people who have survived stage II or III colorectal cancer. Researchers will enroll 30 survivors and randomly assign them to either an exercise group or a health education group. The m…
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC